Active Substance: Hepatitis B Immunoglobulin > 312 IU/mL.
Overview
Welcome to Dwaey, specifically on HEPAGAM B >312 IU/ml (1 ml) page.
This medicine contains an important and useful components, as it consists of
Hepatitis B Immunoglobulin
> 312 IU/mLis available in the market in concentration
Hepatitis B Vaccine (rDNA) BP
If any alcohol or disinfectant is used for cleansing the skin it should be allowed to evaporate before vaccination otherwise inactivation of live vaccines may occur. Lactation: not known if excreted in breast milk
To prevent Hepatiis B virus
Previous confirmed anaphylactic reaction to a previous dose of a vaccine containing the same antigens. Hypersensitivity. Vaccines prepared in egg cultures are contraindicated in patients with hypersensitivity reactions to egg. Severe immunodeficiency. Malignant disease being treated with chemotherapy or radiotherapy and for at least 6 mth after stopping treatment. Patients with compromised immune system such as those on high-dose systemic corticosteroids, immunosuppressants or HIV positive.
>10% Pain (10-29%),Pruritus (10-29%),Erythema (10-29%),Burning (10-29%),Nodules (10-29%),Fatigue (15%),Headache (15%),Fever (15%),Vertigo (15%) 1-10% Lightheadedness,Flushinig,Insomnia,Irritability,Arthralgia,Constipation,Pruritus,Lupus-like syndrome,Lymphadenopathy,Tachycardia
3
Hepatitis B vaccines are used for active immunisation against hepatitis B infection. Two types of vaccine have been available each containing hepatitis B surface antigen (HBsAg) adsorbed onto aluminium hydroxide or a similar adsorbent.
Reduced response to vaccination when used concurrently with immunosuppressants such as corticosteroids or antineoplastics.
Information not available